Considerations in the pharmacologic treatment and prevention of neonatal sepsis. - Wikidata - awgldk - TriplyDB

Considerations in the pharmacologic treatment and prevention of neonatal sepsis.

Considerations in the pharmacologic treatment and prevention of neonatal sepsis.

http://www.wikidata.org/entity/Q38161849

about

Bacterial meningitis in infants A Population and Developmental Pharmacokinetic Analysis To Evaluate and Optimize Cefotaxime Dosing Regimen in Neonates and Young Infants Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants.Bacteremia in children: epidemiology, clinical diagnosis and antibiotic treatment.Pharmacodynamic studies of voriconazole: informing the clinical management of invasive fungal infections.C-reactive protein concentrations can help to determine which febrile infants under three months should receive blood cultures during influenza seasons.Evaluation of Vancomycin Use in Late-Onset Neonatal Sepsis Using the Area Under the Concentration-Time Curve to the Minimum Inhibitory Concentration ≥400 Target.[Update on outbreaks reported from neonatal intensive care units (2010-203): Staphylococcus aureus].Penetration of cefotaxime into cerebrospinal fluid in neonates and young infants.

P2860

Q28082173-75AB9976-E985-4E93-9EBA-C970B1D4F374 Q37358644-03D65E4B-BC81-44A4-8234-7572C908CE98 Q38215682-D91F750C-4EC1-4B78-AE66-F006CFB15C36 Q38542909-9E0679E6-D750-4177-8778-DD43EA2EB74A Q38880522-9592C3B2-BC32-471C-A602-73F00396857A Q40043714-A8625184-5BDC-40B8-B423-C459C0C74F30 Q40327439-4E62CF00-0906-47A6-8BA9-407C7A42CCA5 Q41558214-BED6E3FB-4B68-4539-A078-18FDC7FBDBCD Q50044338-D22BB43B-C568-4862-8CC0-B2302BDF1008

P2860

Considerations in the pharmacologic treatment and prevention of neonatal sepsis.

http://www.wikidata.org/entity/Q38161849

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Considerations in the pharmacologic treatment and prevention of neonatal sepsis.

@en

type

label

Considerations in the pharmacologic treatment and prevention of neonatal sepsis.

@en

prefLabel

Considerations in the pharmacologic treatment and prevention of neonatal sepsis.

@en

P1433

Q38161849-8F8EAFD1-DD1E-494A-BDAE-B61032F2A3A9

P1476

Q38161849-BF4C1646-6446-495F-B64F-AA6D012CD6CD

P2093

Q38161849-1D5BE772-3AD0-43C7-BD11-9315BB0BD7ED

Q38161849-6DC7A82C-F5DD-4290-AD3E-B94DEE268319

Q38161849-76B2E657-07BE-42A0-B8B0-BD7114AAC4F1

Q38161849-96116C11-FEF7-4CF0-A86D-679D437DA923

Q38161849-C95E7E6E-F07C-4EF6-A34C-7BD67C9D2BBD

Q38161849-E5510299-7B42-4836-8EC2-97A43D7EE1AA

P2860

Q38161849-0B3C2880-F9E9-4C86-B327-C2F624550408

Q38161849-0BECA664-6FEF-405A-8545-DABA65218D41

Q38161849-0BFF9BE0-3E9D-4701-B8D0-D584B2EABC82

Q38161849-0EF10E17-8E56-4099-9674-B9A1A49B7D23

Q38161849-0FA79B1D-F74A-45C9-A8DE-EC7BB3AC773F

Q38161849-136AEA9C-8D99-45C0-B0A2-35A20CDE6E2C

Q38161849-149F142A-CEA5-42D0-9B85-8E7227C45B5C

Q38161849-19830633-69A5-42FF-96D8-793EE99B96FF

Q38161849-2178F8C4-60E1-405B-A57A-DB8063CBE050

Q38161849-21FAA216-13C1-4F32-B020-056CD8C9C7DD

P2888

Q38161849-4BFE3E80-05EB-4863-B6B8-0AC6C525C35F

P304

Q38161849-F78A5FE8-E444-42D0-8E13-6E1BBAED4375

P31

Q38161849-26957E4B-A216-4E07-99BF-11BC03063AA3

P356

Q38161849-7A91BE79-5D6D-42B9-BE29-2B42F8516539

P433

Q38161849-93F6D16F-D7AA-491D-A8B8-64F0D52F77AB

P478

Q38161849-9E64C0D4-1479-40BE-BF3D-540265A00B7E

P50

Q38161849-C24B7F07-0746-4AA5-B5CE-5466CFBB40AC

Q38161849-C4330F33-10F0-4D3C-8E0E-3D22C5153B4A

P577

Q38161849-57EE6583-1E61-45DC-86C6-41A10239341A

P6179

Q38161849-B7DDA33C-8240-43B6-80B0-F696CB34B9CE

P698

Q38161849-C9503905-DF15-45BE-81CE-76D9EBFE440A

P921

Q38161849-1409A4EF-F8EB-485D-9BA0-69A560749CCF

P356

S40272-013-0057-X

P1433

Pediatric Drugs

P1476

Considerations in the pharmacologic treatment and prevention of neonatal sepsis

@en

P2093

Emily A Thorell

http://www.w3.org/2001/XMLSchema#string

Jared Olson

http://www.w3.org/2001/XMLSchema#string

Jonathan E Constance

http://www.w3.org/2001/XMLSchema#string

Joshua D Courter

http://www.w3.org/2001/XMLSchema#string

Michael G Spigarelli

http://www.w3.org/2001/XMLSchema#string

Sarah C Campbell

http://www.w3.org/2001/XMLSchema#string

P2860

Revisiting the Need for Vaccine Prevention of Late-Onset Neonatal Group B Streptococcal Disease

Imipenem/Cilastatin

Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants.

Pharmacokinetics of an elevated dosage of micafungin in premature neonates.

Population pharmacokinetics of fluconazole in young infants.

Strategies to prevent invasive candidal infection in extremely preterm infants.

Empirical therapy for neonatal candidemia in very low birth weight infants.

Early and late onset sepsis in late preterm infants.

Inflammatory mechanisms in neonatal chronic lung disease.

Cytochrome P450 3A: ontogeny and drug disposition.

P2888

s40272-013-0057-x

P304

67-81

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40272-013-0057-X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Chris Stockmann

Catherine M Sherwin

P577

2014-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1003415676

http://www.w3.org/2001/XMLSchema#string

P698

24218112

http://www.w3.org/2001/XMLSchema#string

P921